141 related articles for article (PubMed ID: 20582956)
21. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of apoptosis proteins in human cervical cancer.
Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
[TBL] [Abstract][Full Text] [Related]
23. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
24. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter.
Lauten M; Stanulla M; Zimmermann M; Welte K; Riehm H; Schrappe M
Klin Padiatr; 2001; 213(4):169-74. PubMed ID: 11528550
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leukemia; 2004 Mar; 18(3):530-7. PubMed ID: 14724649
[TBL] [Abstract][Full Text] [Related]
27. Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
Lauten M; Beger C; Gerdes K; Asgedom G; Kardinal C; Welte K; Schrappe M
Leukemia; 2003 Aug; 17(8):1551-6. PubMed ID: 12886242
[TBL] [Abstract][Full Text] [Related]
28. Study of survivin and X-linked inhibitor of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML).
Ibrahim AM; Mansour IM; Wilson MM; Mokhtar DA; Helal AM; Al Wakeel HM
Lab Hematol; 2012 Mar; 18(1):1-10. PubMed ID: 22459568
[TBL] [Abstract][Full Text] [Related]
29. Substance P--a potent risk factor in childhood lymphoblastic leukaemia.
Nowicki M; Miśkowiak B
Leukemia; 2003 Jun; 17(6):1096-9. PubMed ID: 12764374
[TBL] [Abstract][Full Text] [Related]
30. Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Lauten M; Schrauder A; Kardinal C; Harbott J; Welte K; Schlegelberger B; Schrappe M; von Neuhoff N
Leukemia; 2006 May; 20(5):820-6. PubMed ID: 16541142
[TBL] [Abstract][Full Text] [Related]
31. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.
Flanagan L; Kehoe J; Fay J; Bacon O; Lindner AU; Kay EW; Deasy J; McNamara DA; Prehn JH
Radiat Oncol; 2015 Jun; 10():131. PubMed ID: 26071313
[TBL] [Abstract][Full Text] [Related]
32. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
33. The expression of histone deacetylase 4 is associated with prednisone poor-response in childhood acute lymphoblastic leukemia.
Gruhn B; Naumann T; Gruner D; Walther M; Wittig S; Becker S; Beck JF; Sonnemann J
Leuk Res; 2013 Oct; 37(10):1200-7. PubMed ID: 23948281
[TBL] [Abstract][Full Text] [Related]
34. Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95-induced apoptosis.
Loeder S; Drensek A; Jeremias I; Debatin KM; Fulda S
Int J Cancer; 2010 May; 126(9):2216-28. PubMed ID: 19676052
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study.
Winter SS; Sweatman J; Shuster JJ; Link MP; Amylon MD; Pullen J; Camitta BM; Larson RS
Leukemia; 2002 Jun; 16(6):1121-6. PubMed ID: 12040442
[TBL] [Abstract][Full Text] [Related]
36. Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.
Yan J; Jiang N; Huang G; Tay JL; Lin B; Bi C; Koh GS; Li Z; Tan J; Chung TH; Lu Y; Ariffin H; Kham SK; Yeoh AE; Chng WJ
Br J Haematol; 2013 Oct; 163(1):93-103. PubMed ID: 23888996
[TBL] [Abstract][Full Text] [Related]
37. Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy.
Tao HF; Liu YS; Fang JL; Su YZ; Chen FH; Zhou LY; Zhu YS
Genet Mol Res; 2014 Mar; 13(1):2020-31. PubMed ID: 24737427
[TBL] [Abstract][Full Text] [Related]
38. mRNA expression of apoptosis-associated genes in infant acute lymphoblastic leukemia: low Fas expression is an independent predictor for poor prognosis.
Suminoe A; Matsuzaki A; Hattori H; Koga Y; Kinukawa N; Ishii E; Hara T
Leukemia; 2004 Feb; 18(2):365-8. PubMed ID: 14647399
[No Abstract] [Full Text] [Related]
39. [Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia].
Xu JY; Luo JM
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):945-949. PubMed ID: 28774373
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
Tissing WJ; Meijerink JP; Brinkhof B; Broekhuis MJ; Menezes RX; den Boer ML; Pieters R
Blood; 2006 Aug; 108(3):1045-9. PubMed ID: 16574952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
